Dr. F. Köhler Chemie Gmbh
Clinical trials sponsored by Dr. F. Köhler Chemie Gmbh, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New solution may keep donor hearts safer for kids Results expected Jan 2027 (estimated)
-
New solution may keep donor hearts safer for kids
Disease control Recruiting nowThis study tests a new liquid (Custodiol-N) used to preserve donor hearts before transplant in children. 15 children receiving their first heart transplant will be randomly assigned to get a heart stored in either the new or standard solution. The main goal is to check if the new…
Phase 2 • Sponsor: Dr. F. Köhler Chemie GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New fluid could keep transplant organs healthier longer
Disease control Recruiting nowThis phase 3 trial tests a new solution called Custodiol-N for preserving donated kidneys, livers, and pancreases before transplant. About 362 recipients will be randomly assigned to receive organs stored in either Custodiol-N or the standard Custodiol solution. The goal is to se…
Phase 3 • Sponsor: Dr. F. Köhler Chemie GmbH • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC